Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients-Reference-Cited by-同舟云学术

Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients

Published:2016-01-27 Issue:2 Volume:14 Page:158-164
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Gebhardt Christoffer¹,Lichtenberger Ramtin¹,Utikal Jochen¹

Affiliation:

1. German Cancer Research Center (DKFZ); Skin Cancer Unit; Heidelberg and University Medical Center Mannheim; Department of Dermatology; Venereology and Allergology; Ruprecht-Karl University of Heidelberg; Mannheim Germany

Publisher

Wiley

Subject

Dermatology

Reference52 articles.

1. Cutaneous melanoma;Eggermont;Lancet,2014

2. New therapeutic options for advanced non-resectable malignant melanoma;Stadler;Adv Med Sci,2014

3. Tumor biomarkers in melanoma;Ugurel;Cancer Control,2009

4. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma;Harpio;Clin Biochem,2004

5. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S100B Serum Levels in Chronic Heart Failure Patients: A Multifaceted Biomarker Linking Cardiac and Cognitive Dysfunction;International Journal of Molecular Sciences;2024-08-22

2. A Retrospective Analysis of the Prognostic Factors and Adverse Events in the Treatment of Mucosal Melanoma in a Single Centre;Journal of Clinical Medicine;2024-08-13

3. Clinical and Imaging Follow-Up for High-Risk Cutaneous Melanoma: Current Evidence and Guidelines;Cancers;2024-07-18

4. Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients;European Journal of Surgical Oncology;2024-07

5. Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment;Translational Oncology;2024-04